Automate Finance for Biotech Firms with Clozure AI

Biotech Finance Teams Are Bleeding Revenue — Here’s How Clozure Stops It

Your biotech firm’s finance department faces a unique triple threat: long sales cycles tied to grant cycles, fragmented payment data from CROs and academic partners, and compliance audits that punish manual errors. Clozure’s autonomous Finance agent turns this chaos into a predictable revenue machine.

Pain Point #1: Grant-Funded Collections That Take 90+ Days

Biotech firms often invoice academic institutions and government agencies. Those invoices sit in limbo for months because your team manually chases AP departments with no insight into intent. Clozure’s intent-classifier scans incoming email traffic and payment histories to flag which accounts are stalling vs. which are ready to pay. Our cold-outreach pipeline then auto-sends personalized follow-ups to slow payers, cutting DSO from 92 days to 38 days for early adopters.

Pain Point #2: Reconciliation Errors That Trigger Audit Flags

When a CRO sends a partial payment with a cryptic reference number, your team spends hours matching it to the correct invoice. One wrong match and a compliance audit becomes a nightmare. Clozure’s multi-mailbox warmup ensures your dedicated finance inboxes (ar@, collections@) stay deliverable and secure. The audit trails feature logs every action — from invoice sent to payment matched — creating a tamper-proof record for FDA and SEC inspections.

Pain Point #3: Missed Revenue Opportunities in Licensing Deals

Your team leaves money on the table when they fail to follow up on milestone payments or licensing renewals. Clozure’s auto-meeting-booking agent scans your contract database, identifies upcoming milestones, and automatically schedules calls with the counterparty’s finance team. No more spreadsheets. No more missed deadlines.

Concrete Workflow: End-to-End Grant Payment Collection

Here’s how a Stanford biotech grant payment flows through Clozure:

1. Invoice sent — Clozure detects the invoice email in your outbox and begins a 7-day warmup sequence on the grant officer’s mailbox.
2. Day 14 — No response — The intent-classifier flags the account as “low engagement.” Clozure’s cold-outreach pipeline sends a personalized video message from your CFO.
3. Day 21 — Payment received — The system auto-matches the payment to the invoice, updates your ERP, and logs the entire interaction in the audit trail.
4. Day 22 — Meeting booked — Clozure’s auto-meeting-booking agent schedules a quarterly review with the grant officer to discuss the next tranche.

Result: Payment collected in 22 days vs. the industry average of 87. One biotech firm using Clozure recovered $340,000 in stalled receivables in the first quarter.

ROI estimate

Enter your monthly conversion goal — we'll show what Clozure can deliver.

Monthly goal Estimate

Calculate Your Biotech Firm’s Potential Recovery

Enter your average invoice value and number of overdue accounts below to see what Clozure can recover for you.

Why Biotech Finance Leaders Choose Clozure

• Cold-outreach pipeline — Automates 100% of follow-up emails to slow-paying partners.
• Intent-classifier — Predicts which accounts will pay within 30 days with 94% accuracy.
• Auto-meeting-booking — Schedules 3x more milestone reviews without human effort.
• Multi-mailbox warmup — Keeps your ar@ and collections@ inboxes out of spam folders.
• Audit trails — Every action timestamped and immutable for compliance reviews.

Start Recovering Biotech Revenue Today

Your finance team shouldn’t spend hours chasing payments. Clozure’s autonomous agent handles the grunt work so you can focus on strategic capital allocation.

Try Clozure for Biotech Firms